The Cancer Network Zurich (CNZ) was initiated to generate synergies, to encourage collaborations and to facilitate communication between clinicians, research scientists and the public at large in matters concerning diagnosis, prognosis, therapy and prevention of cancer. The CNZ offers ambitious and talented students an international PhD program in Cancer Biology.
In order to combat cancer, we need to identify its underlying causes through intensive and multidisciplinary research. Members of the CNZ are leading oncology research experts from the University of Zurich, ETH Zurich, the University Hospital Zurich, the Childrens’ Hospital Zurich, the Balgrist Clinic and the Paul Scherrer Institute, all of whom represent areas of basic, clinical and translational cancer research.
To support further education and networking, the CNZ concentrates on information and practical
know-how exchange, joint seminars and retreats, as well as on the establishment of reagent, cell
and tissue repositories.
The CNZ offers highly motivated and talented students with interest in cancer research an international PhD program as part of the Life Science Zurich Graduate School. Students accepted into this program have the opportunity to attend specialized courses in Molecular and Cell Biology of Cancer, Clinical Cancer Research, Scientific Writing and Ethics.
- CNZ represents areas of basic, clinical and translational cancer research
- CNZ has been created to facilitate communication and collaborations between basic cancer researchers and clinicians
- CNZ includes more than 60 faculty members of the University of Zurich (UZH), ETH Zurich and the Paul Scherrer Institute (PSI)
- CNZ houses an international PhD program in Cancer Biology with over 90 students
Prof. Josef Jiricny, Chair
Dr. Eveline Bergmüller, Coordination
University of Zurich
Institute of Molecular Cancer Research,
Winterthurerstr. 190,
8057 Zurich
Switzerland
